跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 淳昭
副教授
,
麻醉學科
合聘副教授
,
臨床醫學研究所
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0002-9603-5456
電子郵件
nekota
tmu.edu
tw
h-index
1443
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1993 …
2024
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(73)
類似的個人檔案
(9)
指紋
查看啟用 Chuen-Chau Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Odds Ratio
100%
Adverse Outcome
94%
Apoplexy
65%
Retrospective Cohort Study
59%
General Anesthesia
47%
Cohort Analysis
44%
Postoperative Complication
41%
Major Surgery
34%
Hazard Ratio
29%
Diabetes
29%
Meta-Analysis
27%
Surgical Mortality
26%
Neuraxial Anesthesia
23%
Anesthesiology
22%
Adverse Event
22%
Hospital Mortality
21%
Logistic Regression Analysis
21%
Hysteroscopy
20%
Intensive Care Unit
19%
Propensity Score Matching
17%
Septicemia
16%
Patient with Diabetes
16%
Randomized Controlled Trial
15%
Anesthesiologist
15%
Liver Cirrhosis
15%
Chronic Kidney Disease
15%
Traditional Chinese Medicine
14%
Noncardiac Surgery
13%
Liver Surgery
13%
Patient with Epilepsy
13%
Myasthenia gravis
13%
Cholestin
13%
Smoking
12%
Acute Kidney Injury
11%
Surgical Infection
11%
Disease
10%
Surgical Technique
10%
Epidural Anesthesia
9%
Gastrointestinal Bleeding
9%
Surgeon
9%
Analgesia
9%
Quality Improvement
8%
Mortality Rate
8%
Pulmonary Edema
8%
Glycon
8%
Clinical Research
8%
Tracheal Intubation
8%
Hypotension
8%
Mitral Valve Replacement
8%
Urinary Tract Infection
7%
Nursing and Health Professions
Confidence Interval
60%
Adverse Outcome
57%
Odds Ratio
55%
Cohort Analysis
40%
Propensity Score
30%
Major Surgery
21%
Postoperative Complication
20%
Meta Analysis
17%
Disease
16%
Liver Cirrhosis
15%
Surgical Mortality
14%
Liver Surgery
13%
Comorbidity
12%
Hazard Ratio
11%
Hospital Mortality
10%
National Health Insurance
10%
Patient with Diabetes
9%
Intensive Care Unit
9%
Logistic Regression Analysis
9%
Cigarette Filter
8%
Gastrointestinal Hemorrhage
8%
University Hospital
7%
Mortality Rate
7%
Chronic Pancreatitis
6%
Teaching Research
6%
Influenza Vaccination
6%
Artificial Respiration
6%
Wound Complication
6%
Alcohol Liver Disease
6%
Hypotension
6%
General Anesthesia
6%
Urologic Surgery
6%
Parecoxib
6%
Heart Failure
6%
Intellectual Impairment
6%
Sedation
6%
Coronary Artery Atherosclerosis
6%
Dental Scaling
6%
Patient with Epilepsy
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Laparoscopic Cholecystectomy
6%
Pressure Ulcer
6%
Analgesia
6%
Artificial Neural Network
6%
Chronic Kidney Failure
6%
Idiopathic Thrombocytopenic Purpura
6%
Acute Pancreatitis
6%
Thrombocytopenia
6%
Hyperlipidemia
6%
Cholestin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
51%
Spontaneously Hypertensive Rat
31%
Traditional Chinese Medicine
20%
Randomized Controlled Trial
15%
Genistein
13%
Non-Steroidal Anti-Inflammatory Drug
13%
End Stage Renal Disease
13%
Estrogen Receptor Alpha
13%
Chronic Kidney Failure
13%
Adverse Outcome
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Gastrointestinal Hemorrhage
8%
Morphine
8%
Inflammation
8%
Analgesic Agent
8%
Cardiovascular Disease
7%
Ginkgo Biloba Extract
6%
Curcumin
6%
Red Yeast Rice
6%
Cytokine
6%
Parecoxib
6%
Factor A
6%
Heart Failure
6%
Hypotension
6%
Chemokine
6%
Periodontitis
6%
Breast Cancer
6%
Tristetraprolin
6%
Pethidine
6%
Carbon Black
6%
Endotoxin
6%
Intrathecal
6%
Toll Like Receptor 4
6%
Vecuronium
6%
Decubitus
6%
Thrombocytopenia
6%
Myasthenia gravis
6%
Nitric Oxide
6%
Adenosine Triphosphate
6%
Infectious Complication
6%
